Study on Bioequivalence of Omeprazole Enteric-coated Capsules in Healthy Volunteers
Hou Yan-ning
Abstract
Hou Yan-ning
Abstract
Objective:To evaluate the bioequivalence of omeprazole enteric-coated capsule and reference capsule in healthy volunteers.Methods:In a randomized crossover study,22 healthy male volunteers were given a single oral dose of 40 mg test capsules and reference capsules.The concentration of omeprazole in plasma was determined by a RP-HPLC method.Results:After administration of reference capsules and test capsules,the pharmacokinetic parameters were as follows: c_(max)were(0.93±0.57)and(0.98±0.52)μg/ml,respectively;t_(max)were(2.36±0.90)and(2.30±1.04)h,t_(1/2) were(1.18±0.46)and(1.15±0.57)h;AUC_(0~8h)were(2.48±2.09)and(2.48±1.98)μg·h·ml~(-1),AUC_(0~∞) were(2.65±2.39)and(2.65±2.28)μg·h·ml~(-1),respectively.The relative bioavailability of omeprazole enteric-coated capsules was(111.1±58.1)%.Conclusion:The two preparations were bioequivalent.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To evaluate the bioequivalence of omeprazole enteric-coated capsule and reference capsule in healthy volunteers.Methods:In a randomized crossover study,22 healthy male volunteers were given a single oral dose of 40 mg test capsules and reference capsules.The concentration of omeprazole in plasma was determined by a RP-HPLC method.Results:After administration of reference capsules and test capsules,the pharmacokinetic parameters were as follows: c_(max)were(0.93±0.57)and(0.98±0.52)μg/ml,respectively;t_(max)were(2.36±0.90)and(2.30±1.04)h,t_(1/2) were(1.18±0.46)and(1.15±0.57)h;AUC_(0~8h)were(2.48±2.09)and(2.48±1.98)μg·h·ml~(-1),AUC_(0~∞) were(2.65±2.39)and(2.65±2.28)μg·h·ml~(-1),respectively.The relative bioavailability of omeprazole enteric-coated capsules was(111.1±58.1)%.Conclusion:The two preparations were bioequivalent.
Key concepts: Bioequivalence, Omeprazole, Bioavailability, Capsule, Pharmacokinetics, Crossover study, Enteric coated, Medicine